Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Southern Medical Journal|August 12, 2009
Association of myocardial bridge and Takotsubo cardiomyopathy: a case report and literature reviewMoheb Boktor, Ishak A Mansi, Sean Troxclair, et al.
Case Reports in Hepatology|July 19, 2018
Pyogenic Liver Abscess Caused by Methicillin-Susceptible Staphylococcus aureus in a 21-Year-Old MaleSamuel Igbinedion, Meher S Mavuram, Moheb Boktor, et al.
Drug Safety|June 30, 2025
Association of GLP1-Receptor Agonists with Risk of Hepatocellular Carcinoma: A Retrospective Cohort StudyJoane Titus, Vinay Katukuri, Moheb Boktor, et al.
BMJ Case Reports|December 3, 2017
Pseudohyponatraemia secondary to hyperlipidaemia in obstructive jaundiceSamuel O Igbinedion, Sudha Pandit, Meher S Mavuram, et al.
Case Reports in Gastrointestinal Medicine|December 1, 2018
Gastrointestinal Bleeding Secondary to Portal Hypertensive Duodenopathy in a Patient with Decompensated Liver CirrhosisRohini Krishna, Samuel O Igbinedion, Richie Diaz, et al.
American Journal of Medicine Open|December 31, 2025
GLP-1 Receptor Agonists Initiation and Risk of Acute Pancreatitis and Pancreatic Cancer: A Real-World Comparative StudyOmar Faour, Moheb Boktor, Hanford Yau, et al.
Annals of the New York Academy of Sciences|October 22, 2010
Emerging roles of lymphatics in inflammatory bowel diseaseJ Steven Alexander, Ganta Vijay Chaitanya, M B Grisham, et al.
Pathophysiology : the Official Journal of the International Society for Pathophysiology|September 26, 2017
Gastroesophageal reflux disease: A clinical overview for primary care physiciansSudha Pandit, Moheb Boktor, Jonathan S Alexander, et al.
The American Journal of Cardiology|March 19, 2015
Comparison of frequency of inflammatory bowel disease and noninfectious gastroenteritis among statin users versus nonusersDina Khalil, Moheb Boktor, Eric M Mortensen, et al.
Pathophysiology : the Official Journal of the International Society for Pathophysiology|August 19, 2017
Two year follow-up of Crohn's patients substituted to certolizumab anti-TNFa therapy: SAVANT 2Andrew Motlis, Moheb Boktor, Paul Jordan, et al.
Pageof 4